Minerva Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Minerva Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,411	Closed	-$55K	–	75
2015 Q2	$55K	Hold	1,411	–	–	0.03%	71
2015 Q1	$54K	Hold	1,411	–	–	0.03%	70
2014 Q4	$64K	Buy	+1,411	New	+$58.2K	0.04%	74

Other funds holding ASXC

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Minerva Advisors's ASXC Position: Q3 2015 in Review

Minerva Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q3 2015, closing a stake of 1,411 shares — an estimated $55K sold.

Minerva Advisors first reported a position in ASXC in Q4 2014 and held it in 3 quarters. The position peaked at $64K in Q4 2014. 67 funds tracked by Wall St. Rank hold ASXC as of Q3 2015.

Minerva Advisors reported no remaining Asensus Surgical, Inc. position as of Q3 2015 after selling out during the quarter.
Minerva Advisors sold 1,411 Asensus Surgical, Inc. shares in Q3 2015, an estimated $55K.
Minerva Advisors first reported a position in Asensus Surgical, Inc. in Q4 2014 and held it in 3 quarters.
Minerva Advisors's Asensus Surgical, Inc. position peaked at $64K in Q4 2014.
67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2015.

Based on Minerva Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.